Home From Drew Altman

From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have four major program areas: KFF Policy; KFF Polling; KFF Health News (formerly Kaiser Health News); and KFF Social Impact Media, which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.” Read more

Beyond the Data

In his “Beyond the Data” columns, Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

A Note on How the War in Iran May Affect Health Care in the Midterms

In a new column, Dr. Drew Altman, KFF’s President and CEO, discusses the impact of the war in Iran and rising gas prices on voter concerns about health care costs. He writes: “Recently, we saw health care costs rise to the top of the public’s list of economic worries, ahead of food, housing, utility costs and the cost of gas….Expect gas prices to rise and health care costs to fall on the list of affordability worries while the war in Iran lasts, but then to return to the top or near the top when President Trump decides to declare the major hostilities over, the Strait of Hormuz is open, and gas prices come down….health care costs have staying power as one of the top voter concerns.”

View All Beyond the Data Columns

View the Latest: From Drew Altman

Filter

List Grid

131 - 140 of 336 Results

  • The ACA Ruling Shows How the Times Have Changed on Health Care

    From Drew Altman

    In this Axios column about the Texas court decision, Drew Altman shows that many provisions of the Affordable Care Act are even more popular than protections for pre-existing conditions, the issue which put Republicans on the defensive and helped Democrats in the midterm elections.

  • Medicare for All is a Double-Edged Sword for Democrats

    From Drew Altman

    In an Axios column, Drew Altman analyzes the political pros and cons of Medicare for All and Medicare buy-in plans for Democrats, and how they may handle it in Congress and the presidential campaign.

  • The New Health Care Agenda: Gridlock, Lots of Hearings

    From Drew Altman

    In an Axios column, Drew Altman analyzes what the midterm election means for the health policy agenda between now and 2020--mostly political positioning and gridlock in Congress, with most of the action affecting people in the states. 

  • Health Care Gives Democrats a Modest Edge with Senior Voters

    From Drew Altman

    Drew Altman analyzes the senior health care vote in his Axios column. This group, most likely to vote in the midterms, has more Democrats than Republicans and trusts Democrats more on health. They will give Democrats a real but modest advantage in the election.

  • The Role Health Is and Is Not Playing in the Midterms

    From Drew Altman

    With less than two weeks until Election Day, Drew Altman discusses health being the top issue, but not necessarily the top factor in voters' 2018 decisions. He says the longer-term impact of health may be its continuing role in the debate leading up to the 2020 presidential race.

  • Corporate health costs don’t look like a crisis

    From Drew Altman

    n this Axios column, Drew Altman presents a puzzle around corporate health costs: companies are talking like there is a crisis, but new data doesn’t really show it.